Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35732107419;107420;107421 chr2:178528557;178528556;178528555chr2:179393284;179393283;179393282
N2AB34091102496;102497;102498 chr2:178528557;178528556;178528555chr2:179393284;179393283;179393282
N2A3316499715;99716;99717 chr2:178528557;178528556;178528555chr2:179393284;179393283;179393282
N2B2666780224;80225;80226 chr2:178528557;178528556;178528555chr2:179393284;179393283;179393282
Novex-12679280599;80600;80601 chr2:178528557;178528556;178528555chr2:179393284;179393283;179393282
Novex-22685980800;80801;80802 chr2:178528557;178528556;178528555chr2:179393284;179393283;179393282
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-168
  • Domain position: 31
  • Structural Position: 45
  • Q(SASA): 0.4419
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/D None None 0.002 N 0.126 0.049 0.232513804876 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0
E/K None None 0.016 N 0.205 0.217 0.344945010812 gnomAD-4.0.0 6.85714E-07 None None None None I None 0 0 None 0 0 None 0 0 9.0111E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2907 likely_benign 0.2977 benign -0.488 Destabilizing 0.334 N 0.439 neutral N 0.501352557 None None I
E/C 0.9665 likely_pathogenic 0.9762 pathogenic -0.294 Destabilizing 0.992 D 0.601 neutral None None None None I
E/D 0.2511 likely_benign 0.2548 benign -0.58 Destabilizing 0.002 N 0.126 neutral N 0.468240061 None None I
E/F 0.9185 likely_pathogenic 0.9264 pathogenic -0.234 Destabilizing 0.972 D 0.585 neutral None None None None I
E/G 0.3788 ambiguous 0.3959 ambiguous -0.73 Destabilizing 0.549 D 0.519 neutral N 0.504396604 None None I
E/H 0.7258 likely_pathogenic 0.7558 pathogenic -0.112 Destabilizing 0.972 D 0.431 neutral None None None None I
E/I 0.5828 likely_pathogenic 0.5958 pathogenic 0.13 Stabilizing 0.92 D 0.601 neutral None None None None I
E/K 0.2708 likely_benign 0.298 benign -0.098 Destabilizing 0.016 N 0.205 neutral N 0.471221652 None None I
E/L 0.6811 likely_pathogenic 0.6973 pathogenic 0.13 Stabilizing 0.766 D 0.561 neutral None None None None I
E/M 0.6908 likely_pathogenic 0.7035 pathogenic 0.182 Stabilizing 0.992 D 0.566 neutral None None None None I
E/N 0.4597 ambiguous 0.4693 ambiguous -0.409 Destabilizing 0.447 N 0.369 neutral None None None None I
E/P 0.9488 likely_pathogenic 0.9574 pathogenic -0.056 Destabilizing 0.92 D 0.542 neutral None None None None I
E/Q 0.2292 likely_benign 0.2366 benign -0.349 Destabilizing 0.549 D 0.425 neutral N 0.499947048 None None I
E/R 0.432 ambiguous 0.4688 ambiguous 0.203 Stabilizing 0.005 N 0.277 neutral None None None None I
E/S 0.3572 ambiguous 0.3659 ambiguous -0.595 Destabilizing 0.447 N 0.346 neutral None None None None I
E/T 0.3873 ambiguous 0.3937 ambiguous -0.406 Destabilizing 0.617 D 0.516 neutral None None None None I
E/V 0.3597 ambiguous 0.3713 ambiguous -0.056 Destabilizing 0.896 D 0.579 neutral N 0.506547733 None None I
E/W 0.9767 likely_pathogenic 0.9813 pathogenic -0.064 Destabilizing 0.992 D 0.635 neutral None None None None I
E/Y 0.8596 likely_pathogenic 0.8768 pathogenic -0.007 Destabilizing 0.972 D 0.589 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.